Hemodialysis in elderly patients

International Urology and Nephrology

Volumn 32, Issue 1, 2000, Pages 127-135

  Brown, W W ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Elderly; Geriatric; Hemodialysis; Initiation of dialysis; Medical ethics; Survival; Vascular access

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ANTITHROMBOCYTIC AGENT; CREATININE; WARFARIN;

AGED; ALBUMIN BLOOD LEVEL; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; COMORBIDITY; CONFERENCE PAPER; CREATININE BLOOD LEVEL; ELDERLY CARE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MEDICAL ETHICS; MORTALITY; PREVALENCE; RISK FACTOR; SURVIVAL; THROMBOSIS; UREMIA; VASCULAR ACCESS;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CATHETERS, INDWELLING; ETHICS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; RENAL DIALYSIS; RISK FACTORS;

EID: 0033754845     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007167030245     Document Type: Conference Paper

References (69)

1. Peritoneal dialysis in geriatric patients: An overview and introduction
2. Chronic renal failure
3. Aetiology and diagnosis of chronic renal insufficiency in the aged: The role of renal biopsy
4. Aging and the kidney
5. The geriatric dialysis patient
6. End-state renal disease and its management in older adults
7. Aged-adjusted normal standards for creatinine clearance in man
8. Geriatric polypharmacy
9. Hemodialysis in the eighth and ninth decades of life
10. Mortality, morbidity and life satisfaction in the very old dialysis patient
11. Must patients over 65 be haemodialyzed?
12. Optimum dialysis treatment for patients over 60 years with primary renal disease. Survival data and clinical results from 242 patients treated either by hemodialysis or hemofiltration
13. Dialysis for the elderly: Survival and risk factors
14. Results of renal replacement therapy in Europe, 1980-1987
15. Report on management of renal failure in Europe, XXV, 1994 End Stage Renal Disease and Dialysis Report
16. Mortality in chronic hemodialysis patients in Japan
17. Dialysis treatment in Australia, 1982-1988
18. Results from the Canadian Renal Failure Registry
19. Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients
20. Cardiovascular risk factors, comorbidity, and survival outcomes in black and white dialysis patients
21. The management of uraemia in the elderly: Treatment choices
22. Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors
23. Elderly patients in chronic hemodialysis: Risk factors for left ventricular hypertrophy
24. Cardiac disease in chronic uremia: Investigation
25. Cardiac disease in uremia: Clinical outcome and risk factors
26. Blood pressure elevation during the night in chronic renal failure, hemodialysis and after renal transplantation
27. Ambulatory blood pressure and left ventricular mass in cyclosporin and non-cyclosporin treated renal transplant recipients
28. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension
29. Vascular access survival among incident hemodialysis patients in the United States
30. Opinion: What can be done to preserve vascular access for dialysis?
31. Predictors of permanent vascular access placement prior to ESRD in U.S. hemodialysis patients
32. Predictors of type of vascular access in patients starting hemodialysis
33. Opinion: What can be done to preserve vascular access for dialysis?
34. Opinion: What can be done to preserve vascular access for dialysis?
35. Vascular access for hemodialysis
36. Dialysis outcome quality initiative clinical practice guideline for vascular access
37. The surgical approach to dialysis access and transplantation in the elderly
38. Canadian hemodialysis morbidity study
39. Heparin cofactor II deficiency in the elderly: Comparison with antithrombin III
40. Vascular access: Concepts for the 1990s. Editorial Review
41. Opinion: What can be done to preserve vascular access for dialysis?
42. Prevention of thrombosis in patients on hemodialysis by low-dose aspirin
43. Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis
44. Social and ethical problems in the treatment of end-stage renal disease patients
45. Witholding and withdrawing dialysis from elderly ESRD patients: Part I. A historical review of the clinical experience
46. Over 50 and uremic
47. Inequalities in chronic dialysis and transplantation in Sweden
48. Racial, sexual and age inequalities in chronic dialysis
49. Rate of change of end-stage renal disease treatment incidence, 1978-1987. Has there been selection?
50. Patterns of low incidence of treated endstage renal disease among the elderly
51. Age as a risk factor for inadequate treatment
52. Rationing of health care and the end-stage renal disease program
53. Issues of age and chronic care: Another argument for health care reform
54. An overview of allocation and rationing: Implications for geriatrics
55. Ethical issues in geriatric nephrology: Overview
56. High technology health care
57. Ethical issues in geriatric nephrology
58. Mortality, morbidity and life satisfaction in the very old dialysis patient
59. Hemodialysis and the elderly patient: Potential advantages as to quality of life, urea generation, serum creatinine and less interdialytic weight gain
60. Assisted survival, aging, and rehabilitation needs: Comparison of older dialysis patients and age-matched peers
61. Rehabilitation, aging and chronic renal disease
62. Old patients and uremia: Rates of acceptance to and withdrawal from dialysis
63. To use dialysis appropriately: The emerging consensus on patient selection guidelines
64. Dialysis patients' attitudes about cardiopulmonary resuscitation and stopping dialysis